National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer

Featured Clinical Trials

Cancer Studies Highlighted in the NCI Cancer Bulletin
< Back to Main

Related Pages
Search for Clinical Trials 1
NCI's PDQ® Cancer Clinical Trials Registry.

Colon and Rectal Cancer Home Page 2
NCI's gateway for information about colon and rectal cancer.
Colon and Rectal Cancer - Featured Clinical Trials

The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:

1.  Comparison of Chemotherapy Combinations for Colon Cancer 5
(Posted: 10/05/2004, Updated: 10/28/2008) - Researchers with this study are comparing combination chemotherapy and biological therapy regimens for stage III colon cancer following surgery.

2.  More Effective Treatment for Colorectal Metastases to the Liver 6
(Posted: 03/22/2005, Updated: 06/13/2008) - In this phase II study, researchers are using a surgical procedure known as isolated hepatic perfusion (IHP) to deliver melphalan, an anticancer drug, directly to the liver while avoiding unnecessary systemic toxicity.

3.  Selenium to Prevent Recurrence of Colorectal Polyps 7
(Posted: 05/27/2008) - In this trial, patients who have a history of colorectal adenoma--noncancerous growths (polyps) found in the colon or rectum that can be precursors to colorectal cancer--will be randomly assigned to receive daily selenium supplements or a placebo for 3 or 5 years.

4.  Continuing Bevacizumab Therapy for Metastatic Colorectal Cancer 8
(Posted: 03/04/2008) - In this trial, patients with metastatic colorectal cancer that has progressed on first-line therapy containing oxaliplatin and bevacizumab will be treated with the agents irinotecan and cetuximab. The patients will also be randomly assigned to receive continued bevacizumab or no additional bevacizumab.

5.  Treating Colorectal Cancer Liver Metastases 9
(Posted: 01/16/2007, Updated: 10/23/2007) - In this trial, colorectal cancer patients with six or fewer hepatic metastases will undergo primary surgery and/or ablation and then be treated with oxaliplatin and capecitabine. Half of the patients will receive additional chemotherapy consisting of floxuridine pumped directly into their livers through an arterial catheter and pump.
1 2 10 3 11 4 12   Next > 10


Table of Links

1http://www.cancer.gov/clinicaltrials/search
2http://www.cancer.gov/cancertopics/types/colon-and-rectal
3http://www.cancer.gov/clinicaltrials/ft-more-than-one-type
4http://www.cancer.gov/clinicaltrials/ft-supportive-care
5http://www.cancer.gov/clinicaltrials/ft-NCCTG-N0147
6http://www.cancer.gov/clinicaltrials/ft-NCI-04-C-0229
7http://www.cancer.gov/clinicaltrials/ft-UARIZ-00-0430-01
8http://www.cancer.gov/clinicaltrials/ft-SWOG-S0600
9http://www.cancer.gov/clinicaltrials/ft-NSABP-C-09
10http://www.cancer.gov/clinicaltrials/ft-colon-cancer?keyword=Colon+rectal&page=2
11http://www.cancer.gov/clinicaltrials/ft-colon-cancer?keyword=Colon+rectal&page=3
12http://www.cancer.gov/clinicaltrials/ft-colon-cancer?keyword=Colon+rectal&page=4